BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22315420)

  • 1. Human genetic variation altering anthrax toxin sensitivity.
    Martchenko M; Candille SI; Tang H; Cohen SN
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2972-7. PubMed ID: 22315420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
    Scobie HM; Rainey GJ; Bradley KA; Young JA
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
    Martchenko M; Jeong SY; Cohen SN
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptors that mediate the direct lethality of anthrax toxin.
    Liu S; Zhang Y; Hoover B; Leppla SH
    Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
    Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
    Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression.
    Zhang Z; Zhang Y; Shi M; Ye B; Shen W; Li P; Xing L; Zhang X; Hou L; Xu J; Zhao Z; Chen W
    Toxins (Basel); 2015 Dec; 8(1):. PubMed ID: 26703731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interaction between anthrax toxin and its cellular receptors.
    Liu S; Leung HJ; Leppla SH
    Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted silencing of anthrax toxin receptors protects against anthrax toxins.
    Arévalo MT; Navarro A; Arico CD; Li J; Alkhatib O; Chen S; Diaz-Arévalo D; Zeng M
    J Biol Chem; 2014 May; 289(22):15730-8. PubMed ID: 24742682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain-dependent cytoskeletal rearrangement exploited for anthrax toxin endocytosis.
    Jeong SY; Martchenko M; Cohen SN
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):E4007-15. PubMed ID: 24085852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthrax edema toxin impairs clearance in mice.
    Sastalla I; Tang S; Crown D; Liu S; Eckhaus MA; Hewlett IK; Leppla SH; Moayeri M
    Infect Immun; 2012 Feb; 80(2):529-38. PubMed ID: 22104108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor.
    Dawson RM
    J Pharmacol Toxicol Methods; 2009; 59(1):50-5. PubMed ID: 19049885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
    Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
    J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
    Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN
    Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
    Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
    PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
    Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
    Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
    Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
    J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dark sides of capillary morphogenesis gene 2.
    Deuquet J; Lausch E; Superti-Furga A; van der Goot FG
    EMBO J; 2012 Jan; 31(1):3-13. PubMed ID: 22215446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of anthrax toxin is influenced by receptor expression.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Sep; 15(9):1330-6. PubMed ID: 18596206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.